Krafft, U., Olah, C., Reis, H., Kesch, C., Darr, C., Grünwald, V., . . . Szarvas, T. (2021). High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy. Cancers (Basel).
Citación estilo ChicagoKrafft, Ulrich, et al. "High Serum PD-L1 Levels Are Associated With Poor Survival in Urothelial Cancer Patients Treated With Chemotherapy and Immune Checkpoint Inhibitor Therapy." Cancers (Basel) 2021.
Cita MLAKrafft, Ulrich, et al. "High Serum PD-L1 Levels Are Associated With Poor Survival in Urothelial Cancer Patients Treated With Chemotherapy and Immune Checkpoint Inhibitor Therapy." Cancers (Basel) 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.